WALDENSTRÖM'S MACROGLOBULINEMIA (WM)

Clinical trials for WALDENSTRÖM'S MACROGLOBULINEMIA (WM) explained in plain language.

Never miss a new study

Get alerted when new WALDENSTRÖM'S MACROGLOBULINEMIA (WM) trials appear

Sign up with your email to follow new studies for WALDENSTRÖM'S MACROGLOBULINEMIA (WM), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1 Not yet finished but already full! 1

Tracking a cancer Drug's Real-World impact

Disease control Ongoing

This study is observing how well the drug zanubrutinib works and what side effects patients experience in real-world medical practice in Italy. It includes 212 adults with Waldenström's Macroglobulinemia, a rare blood cancer, who were treated through a special access program or a…

Matched conditions: WALDENSTRÖM'S MACROGLOBULINEMIA (WM)

Sponsor: Fondazione Italiana Linfomi - ETS • Aim: Disease control

Last updated Feb 27, 2026 15:19 UTC

WALDENSTRÖM'S MACROGLOBULINEMIA (WM)

Get alerted when new WALDENSTRÖM'S MACROGLOBULINEMIA (WM) trials appear

Tracking a cancer Drug's Real-World impact